Singapore, Dec 21, 2011: China Sky One Medical, a leading fully integrated pharmaceutical company in China, has announced that Mr Yanqing Liu, the company's chief executive officer and chairman, was sent to the hospital due to a massive hemorrhage of his intestinal tract that occurred on December 17th, 2011. Mr Liu is going to undertake further medical examination and tests and will receive the necessary treatment. Mr Jianping Li, the company's general manager and a board director, has been delegated to supervise the Company's daily operations during Mr. Liu's sick leave.

China Sky One Medical engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology, Harbin First Bio-Engineering, Heilongjiang Tianlong Pharmaceutical and Peng Lai Jin Chuang Pharmaceutical, the company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source.

Source:BioSpectrum Bureau